Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma - Concepedia

Concepedia

Publication | Open Access

Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma

DOI Full Paper Access

76

Citations

35

References

2012

Year

Jian Shen, Weizhi Wang, Jindao Wu, Bing Feng, Wen Chen, Meng Wang, Jincao Tang, Fuqiang Wang, Feng Cheng, Liyong Pu,

Abstract

We successfully constructed a proteomic profile of CC bile proteins, providing a valuable pool novel of candidate biomarkers. SSP411 has potential as a biomarker for the diagnosis of CC.

References

	Year	Citations
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore Jason E. Kokoszka, Katrina G. Waymire, Shawn Levy, Nature Mitochondrial FunctionBiochemistryNatural SciencesMembrane TransportPhysiology	2004	1.1K
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis Kelly W. Burak, Paul Angulo, Tousif M. Pasha, The American Journal of Gastroenterology GastroenterologyPathologyPrimary Biliary CirrhosisCholangiopathiesAutoimmune Liver Disease	2004	549
Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study Tania M. Welzel, Barry I. Graubard, Hashem B. El‐Serag, Clinical Gastroenterology and Hepatology EpidemiologyCancer RiskHepatologyCancer EpidemiologyMedicine	2007	516
High lifetime risk of cancer in primary sclerosing cholangitis Marian M. Claessen, Frank P. Vleggaar, Kristien M.A.J. Tytgat, Journal of Hepatology HepatologyBiliary TractBiliary CancerGastroenterologyPathology	2008	409
Characterization of serum biomarkers for detection of early stage ovarian cancer Katherine R. Kozak, Feng Su, Julian P. Whitelegge, PROTEOMICS Biomarker (Medicine)Prognostic BiomarkersOncologyEngineeringCancer Detection	2005	313
Proteomics in Early Detection of Cancer Pothur R. Srinivas, Sudhir Srivastava, Samir Hanash, Clinical Chemistry	2001	255
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience Sung‐Gyu Lee Journal of Hepato-Biliary-Pancreatic Sciences	2009	254
Target discovery in small-molecule cell-based screens by in situ proteome reactivity profiling Michael J. Evans, Alan Saghatelian, Erik J. Sorensen, Nature Biotechnology Proteomic TechnologyTarget DiscoveryNatural SciencesMedicineMolecular Biology	2005	227
Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study Tania M. Welzel, Lene Mellemkjær, Gloria Gridley, International Journal of Cancer	2006	195
Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality Satoshi Hirano, Satoshi Kondo, Eiichi Tanaka, Journal of Hepato-Biliary-Pancreatic Sciences	2009	162

Page 1